Literature DB >> 7529297

Unexpected expression of intermediate filament protein genes in human oligodendroglioma cell lines.

T Kashima1, H V Vinters, A T Campagnoni.   

Abstract

From a human oligodendroglioma cell line cDNA library, ten intermediate filament (IF) cDNA clones were isolated. Five clones corresponded to vimentin mRNA, two corresponded to cytokeratin K7 mRNA, and two corresponded to cytokeratin K8 mRNA. One clone encoded a novel IF mRNA. The expression of these and other IF protein genes was examined in five cell lines derived from human oligodendroglioma, astrocytoma and neuroblastoma tumors. Vimentin mRNA and K18 mRNA were expressed in all the cell lines. The K7 and K8 genes were expressed only in the oligodendroglioma cell lines. Surprisingly, nestin mRNA was expressed in the astrocytoma lines and the neuroblastoma line, but was not expressed in the oligodendroglioma lines. These results indicate that oligodendroglioma cell lines express Types I and II cytokeratin genes. This pattern of IF gene expression was different from that of the astrocytoma and neuroblastoma cell lines, which expressed IF genes usually associated with the mature cell types or with differentiating fetal neural precursor cells, i.e. GFAP and neurofilament-L. The results also suggest that the oligodendroglioma cell lines are more epithelial in character and do not reflect the gene expression of mature oligodendrocytes.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7529297     DOI: 10.1097/00005072-199501000-00003

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  8 in total

Review 1.  Intermediate filaments in the nervous system: implications in cancer.

Authors:  C L Ho; R K Liem
Journal:  Cancer Metastasis Rev       Date:  1996-12       Impact factor: 9.264

Review 2.  Developmental neurobiology and the origin of brain tumors.

Authors:  Alan H Shih; Eric C Holland
Journal:  J Neurooncol       Date:  2004-11       Impact factor: 4.130

3.  Complement regulatory protein expression by a human oligodendrocyte cell line: cytokine regulation and comparison with astrocytes.

Authors:  P Gasque; B P Morgan
Journal:  Immunology       Date:  1996-11       Impact factor: 7.397

4.  Preventing growth of brain tumors by creating a zone of resistance.

Authors:  Casey A Maguire; Dimphna H Meijer; Stanley G LeRoy; Laryssa A Tierney; Marike L D Broekman; Fabricio F Costa; Xandra O Breakefield; Anat Stemmer-Rachamimov; Miguel Sena-Esteves
Journal:  Mol Ther       Date:  2008-08-19       Impact factor: 11.454

5.  Real-time monitoring of nuclear factor kappaB activity in cultured cells and in animal models.

Authors:  Christian E Badr; Johanna M Niers; Lee-Ann Tjon-Kon-Fat; David P Noske; Thomas Wurdinger; Bakhos A Tannous
Journal:  Mol Imaging       Date:  2009 Sep-Oct       Impact factor: 4.488

6.  Induction of humoral responses to BHV-1 glycoprotein D expressed by HSV-1 amplicon vectors.

Authors:  Andrea Maria Blanc; Mabel Beatriz Berois; Lorena Magalí Tomé; Alberto L Epstein; Juan Ramón Arbiza
Journal:  J Vet Sci       Date:  2012-03       Impact factor: 1.672

7.  Protein Kinase A Distribution Differentiates Human Glioblastoma from Brain Tissue.

Authors:  Carla Mucignat-Caretta; Luca Denaro; Domenico D'Avella; Antonio Caretta
Journal:  Cancers (Basel)       Date:  2017-12-21       Impact factor: 6.639

8.  Caspase-2 short isoform interacts with membrane-associated cytoskeleton proteins to inhibit apoptosis.

Authors:  Chunhua Han; Ran Zhao; John Kroger; Meihua Qu; Altaf A Wani; Qi-En Wang
Journal:  PLoS One       Date:  2013-07-01       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.